Poul Strange Joins Extend Biosciences as Chief Medical Officer

Poul Strange, MD PhD, has joined the clinical team at Extend Biosciences to spearhead the Phase 1 trial of EXT608 in healthy volunteers. Dr. Strange is the Founder and serves as the Medical Director and President of Integrated Medical Development, a US full service clinical CRO focused assisting companies with their medical product development. IMD will be responsible for data management of the trial.